Luca D'Onofrio

Pubblicazioni

Titolo Pubblicato in Anno
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk THE LANCET REGIONAL HEALTH. EUROPE 2024
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study CLINICAL THERAPEUTICS 2024
Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials DIABETES, OBESITY AND METABOLISM 2023
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Development of a clinical risk score to predict death in patients with COVID-19 DIABETES/METABOLISM RESEARCH AND REVIEWS 2022
Third dose of Covid-19 vaccine in diabetes: relevance of good metabolic control to improve its efficacy DIABETES/METABOLISM RESEARCH AND REVIEWS 2022
Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2022
Corneal confocal microscopy identifies small nerve fibre damage in patients with hypertriglyceridemia JOURNAL OF CLINICAL LIPIDOLOGY 2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study ANTIOXIDANTS 2022
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I DIABETES/METABOLISM RESEARCH AND REVIEWS 2022
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA FRONTIERS IN ENDOCRINOLOGY 2022
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study DIABETIC MEDICINE 2021
Small nerve fiber damage and Langerhans cells in type 1 and type 2 diabetes and LADA measured by corneal confocal microscopy INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 2021
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study DIABETES, OBESITY AND METABOLISM 2021
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis INTERNAL AND EMERGENCY MEDICINE 2021

Progetti di Ricerca

Gruppi di ricerca

Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma